In vivo pharmacology

DRF - An Indian Contract Research Organization

in vivo pharmacology services
in vivo pharmacology cro
Ayurvedic product development
Toxicology Studies

Dabur Research Foundation (DRF) is an Indian Contract Research Organization offering preclinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies. We offer preclinical services to global Biotech, Pharma, Phytopharmaceuticals Cosmeceuticals, and academia sectors Read More

preclinical toxicology studies

DIFFERENTIATOR

Contract Research Organization
Why Entrust Us?

The core team of DRF looks back on more than 20 years of their experience in conducting preclinical studies and commercializing molecules.

Read More
preclinical drug development
Alternates To Animal

Dabur Research Foundation offers various in vitro or ex vivo models serving as alternatives to animal testing by focusing on the 3R’s principle

Read More
preclinical CRO in india
Customized Services

Dabur Research Foundation recognizes the need for out of the box thinking to enable for rapid & cost effective preclinical development of molecules

Read More
Indian Contract Research Organization

SERVICES

preclinical toxicology studies

FACILITIES

Contract Research Organization

DRF has designated laboratories for Necropsy, biochemistry and histopathology equipped with state of art/fully automatic equipments such as hematology analyzer, biochemistry analyzer, coagulation analyzer, tissue processor, microtome and etc. know More

preclinical drug development
  • The facility maintains its standard as one of the best facilities in India.
  • It houses P-II laminar air hoods and is equipped with Nikon inverted phase-contrast microscopes, CO2 sensor incubators, centrifuges, refrigerators, deep freezers & controlled cryopreservation units. Know More
preclinical CRO in india
  • The GLP certified facility is equipped for small animal experimentation with quarantine, breeding and experimental rooms for rodents and rabbits.
  • Animal experimentation is under the control of the Institutional Animal Ethics Committee (IAEC), and animal use as per the guidelines of Government of India. Know More
Indian Contract Research Organization

In a campuse of approximately 60000 square feet area Dabur Research Foundation is a one-stop shop for your preclinical needs. The state-of-the-art GLP facility is ready having 19 experimental rooms. This facility is centrally know More

drug discovery and development
  • Test item control unit- Dedicated test item control officer
  • Storage condition maintained as per requirement & Access Control
  • TI receipt, issue and utilization records maintained. Know More
In vitro pharmacology

The state-of-art instrumentation lab at DRF provides in depth analytical services to support the analytical needs for API, NCEs, Agrochemical Testing (physicochemical Testing and five Batch Analysis), UVCB’s, CMC testing, Herbal drug characterization, DMPK (Drug Metabolism and Pharmacokinetics, Bioanalysis), other chemical analysis. Know More

In vivo pharmacology

NEWS & EVENTS

In vivo pharmacology

PRESS RELEASE

Date: 28th March 2024

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development.

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF Lifesciences, an established contract research organisation, aimed at combining the strengths of Partex's advanced AI & data services technology and Althea’s screening services and compounds.

The immediate scope of this exciting partnership is to provide end-to-end services from AI-driven drug discovery to wet lab validations to accelerate drug development.

Dr. Gunjan Bhardwaj, CEO of Partex, expresses enthusiasm about this innovative collaboration, stating, “We have been following Althea for quite some time and this collaboration is a logical next step for both companies in driving innovation in drug discovery. It will allow us to further strengthen our product development in many ways, and it will drive more future innovations.”

in vivo pharmacology services

DRF MANAGEMENT

Ayurvedic product development

Dr. Anu T. Singh

COO
Doctorate in Translational Tumor Biology from AIIMS and Post doctoral research in signal transduction alterations in adenocarcinomas at NII, Dr Anu is a seasoned scientific leader with over 30 years of experience in new drug discovery and early. Read More
in vivo pharmacology cro

Dr. Manu Jaggi

Chief Mentor
Doctorate in Cancer biology from NII and a Post graduate in pharmaceutical science (gold medalist) Dr Jaggi is a seasoned scientific leader bringing over 30 years of experience in discovery research and advanced preclinical drug development. Read More